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Orthostatic hypotension (OH) is a debilitating condition very common in the elderly that may leads to
syncope. There is no single drug able to limit the fall in blood pressure in patients affected by OH when
standing. In addition, the presence of hyperkinetic arrhythmias may worsen the fall in orthostatic blood
pressure especially in elderly patients affected by OH. Unfortunately most of antiarrhythmic therapies
lead to a decrease in blood pressure contrasting the effect of OH treatment. By contrast, disopyramide
seems to have an anticholinergic effect that could play an important role in limiting the fall in blood
pressure in participants with hyperkinetic arrhythmias and OH. We report a case of successful combi-
nation therapy of ﬂudrocortisone, disopyramide and nonpharmacologic treatment in an elderly partic-
ipant affected by neurogenic orthostatic OH and hyperkinetic arrhythmias with a poor quality of life and
frequent syncope episodes.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Orthostatic hypotension (OH) is deﬁned as a reduction in
systolic blood pressure of 20 mmHg or diastolic blood pressure of
 10 mm Hg within 3 minutes upon standing which often leads to
syncope1. OH, a common condition in the elderly, results in
a cerebral hypoperfusion when passing from supine to upright
position2,3. Although OH may be easily diagnosed, therapeutical
approach is difﬁcult, leading to a markedly reduced quality of life
especially in elderly participants4. Furthermore, OH may be wors-
ened by supraventricular cardiac arrhythmia5.
We report a case of successful combination treatment in an
elderly participant affected by neurogenic OH and supraventric-
ular cardiac arrhythmia resulting in frequent episodes of
syncope.erest.
ento di Medicina Clinica e
a di Geriatria, University of
iwan Society of Geriatric Emergen2. Case report
A man aged 65 years reported a 5-year history of episodes of
syncope occurring by changing position (i.e., rising from the bed or
chair). Together with a previous myocardial infarction and subse-
quent revascularization with preserved diastolic and systolic
cardiac function (ejection fraction¼ 65%), the patient was affected
by depression, hypercholesterolemia, bilateral hearing impairment,
and decreased visual acuity. Cerebral neurodegeneration was not
reported. Current therapy was salicylate, paroxetine, and simvas-
tatin. A dual-chamber pacemaker was previously implanted for
a marked sinus bradycardia. However, the patient reported dizzi-
ness, blurred vision and nausea, often preceding episodes of
syncope. At the admission, in supine position the patient had
a resting heart rate (HR) of 70 bpm and a blood pressure (BP) of
140/80 mm Hg. However, after 2 minutes in a standing position, BP
reduced to 70/40 mm Hg and HR was 65 bpm with a disorientated
state that rapidly reverted in clinostatic position. Since his HR did
not increase during standing, neurogenic OH was suspected and
successively conﬁrmed by Valsalva manoeuvre. Multidimensional
geriatric assessment evidenced amild cognitive impairment, a mildcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Therapeutical sequence in treating orthostatic hypotension and syncope.
Procedures or Drugs Clino-BP
(mmHg)
Ortho-BP
(mmHg)
Syncope/
week (n.)
No treatment 120/70 70/40 4
Dietary and behavioral approaches 130/70 80/50 4
þ Application of the
compression stockings
125/75 80/55 3
þ Midodrine 10 mg/da 140/80 80/55 3
þ Fludrocortisone 0.3 mg/d 170/90 90/60 1
þ Disopyramide 200 mg/d 160/90 105/70 0
BP¼ blood pressure.
a Discontinued (see text for details).
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importantly, a complete disability of basic activities of daily living
(4/6 lost). Blood tests showed normal age-related ﬁndings. Echo-
cardiography showed a mild cardiac hypertrophy and mild aortic
insufﬁciency. Carotid Doppler ultrasound showed no signiﬁcant
alterations. The 24-hour Holter electrocardiogram (ECG) showed
frequent episodes of atrial tachycardia with a ventricular rate of
150 bpm. Thus, the diagnosis was orthostatic syncope in a partici-
pant with neurogenic OH and supraventricular arrhythmia. Fluid
intake (up to 2 liters 24 hours) and salts increased, time spent in
upright position reduced, abrupt passage from supine to standing
position avoided and application of the compression stockings
accomplished poor results. Midodrine (10 mg/day) was adminis-
tered but quickly discontinued because of scalp paresthesias and no
effect on OH. Fludrocortisone 0.1 mg up to 0.3 mg daily was
prescribed. The patient no longer experienced episodes of syncope
but dizziness and blurred vision were reported. Orthostatic BP test
revealed a fall of BP from 165/90 mm Hg to 90/60 mm Hg without
changes of HR (HR from 70 bpm to 68 bpm; Table 1). Because of
supraventricular arrhythmia (Fig. 1), the patient started therapy
with disopyramide 200 mg/day with the resolution of arrhythmias
associated with a reduction of symptoms related to orthostatic
stress after 10 days. Over 3 months, the patient reported supine
hypertension of 185/95 mm Hg and ﬂudrocortisone was dis-
continued. After 1 month, symptoms worsening and an increase in
the number of syncopal episodes (three per month) were observed.
Fludrocortisone 0.3 mg daily was resumed and symptoms rapidly
improved. During in-hospital stay ECG did not show arrhythmias
and disopyramide therapy was discontinued. However, after 72
hours the patient presented orthostatic symptoms andFig. 1. (A) Supraventricular tachycardia before;disopyramide was promptly resumed. After 3 years of follow-up,
only ﬁve episodes of presyncope were observed (Table 1) and the
patient fully recovered basic activities of daily living (1/6 lost).3. Discussion
Management of OH should aim to raise orthostatic BP without
concomitant rising in supine BP, and, more importantly, to reduce
orthostatic symptoms and to improve the ability to perform daily
activities, especially in the elderly5,6. Volume expansion,
compression garments, and education about orthostatic stressors
and warning symptoms are used to reduce the degree and the
symptoms of OH6,7. In our case all these procedures had poor effects
on preventing syncope caused by OH.
Several drugs, such as midodrine, ﬂudrocortisone and dis-
opyramide, have been used to treat recurrent vasovagal syncope
with poor efﬁcacy, especially in the elderly8. Fludrocortisone is
a synthetic mineral corticoid with an action on both volume plasma
expansion and increase of vascular alpha-adrenoceptor sensitivity6.
Recently, POST II, a multicenter, international, randomized,
placebo-controlled study, has been designed to assess the effects of
ﬂudrocortisone in the prevention of neurally mediated syncope
with time to ﬁrst recurrence of syncope as primary end point9.
However, hypertension may limit the use of ﬂudrocortisone. In our
case, even in the presence of clinostatic hypertensive values, an
improvement in orthostatic BP was observed and no episode of
syncope occurred. It has also been suggested that agents with
anticholinergic, antiarrhythmic and negative inotropic effects, such
as disopyramide, can be effective in patients with syncope caused
by OH6,7. It has been reported that oral disopyramide therapy in
patients with recurrent episodes of syncope was effective in pre-
venting inducible and spontaneous neurally mediated syncopes10.
Successively, a double-blind randomized trial demonstrated that
both intravenous and oral administration of disopyramide were
ineffective for the prevention of neurally mediated syncope
provoked by head-up tilt testing11. In our patient, disopyramidewas
basically prescribed to treat arrhythmias. At the second admission
the effect of disopyramide on orthostatic BP was not related to the
action on arrhythmias: when the drugwas discontinued orthostatic
BP worsened in the absence of arrhythmias.
In our case, ﬂudrocortisone and disopyramide seemed to act
synergistically as demonstrated by the reduction of OH, of theand (B) after disopyramide administration.
A. Langellotto et al.126number of syncope episodes, and by the recovery of basic activities
of daily living. The stiffness and less compliance of cardiovascular
system may make similar reduction of intravascular volumes more
prone to hypotension development in which the prescription of
ﬂudrocortisone and disopyramide may play a role12.
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